A study by Zhou et al. [61] identified a dominant gain-of-function missense mutation in NLRP3 (R779C), in patients with very-early-onset inflammatory bowel disease (VEOIBD), a chronic inflammatory condition affecting the gastrointestinal tract during infancy or early childhood. The gene discussed is NLRP3; the disease is inflammatory bowel disease.